KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Interest Coverage Ratio: 2011-2024

Historic Interest Coverage Ratio for Esperion Therapeutics (ESPR) over the last 14 years, with Dec 2024 value amounting to 0.92.

  • Esperion Therapeutics' Interest Coverage Ratio rose 57.50% to -0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.37, marking a year-over-year decrease of 231.85%. This contributed to the annual value of 0.92 for FY2024, which is 134.81% up from last year.
  • Latest data reveals that Esperion Therapeutics reported Interest Coverage Ratio of 0.92 as of FY2024, which was up 134.81% from -2.64 recorded in FY2023.
  • Esperion Therapeutics' 5-year Interest Coverage Ratio high stood at 0.92 for FY2024, and its period low was -5.35 during FY2020.
  • In the last 3 years, Esperion Therapeutics' Interest Coverage Ratio had a median value of -2.64 in 2023 and averaged -1.63.
  • Data for Esperion Therapeutics' Interest Coverage Ratio shows a peak YoY skyrocketed of 134.81% (in 2024) over the last 5 years.
  • Over the past 5 years, Esperion Therapeutics' Interest Coverage Ratio (Yearly) stood at -5.35 in 2020, then increased by 8.66% to -4.89 in 2021, then soared by 35.40% to -3.16 in 2022, then increased by 16.52% to -2.64 in 2023, then surged by 134.81% to 0.92 in 2024.